9th Annual Biomarkers Congress

View Profile


Clinical Trial Activity

Start year End year Protocols Investigators Notes
1. 2001 Treatment of relapsed and refractory non-Hodgkin=s lymphoma with continuous low dose cyclophosphamide and Celebrex: a multicentre phase II study Dr. Rena Buckstein and Dr. Michael Crump
2. 2001 Pilot study of low dose chemotherapy and cyclo-oxygenase-2 inhibitor as anti-angiogenic therapy in children with progressive or recurrent solid tumors Dr. Sylvain Baruchel
3. 2001 APhase II trial of continuous low dose cyclophosphamide and celecoxib in patients with progressive advanced renal cell carcinoma Dr. Ian Tannock
4. 2001 AA phase II trial of continuous low dose cyclophosphamide and low dose dexamethasone in hormone refractory prostate cancer Dr. Michael Glode
5. 2001 AA pilot study of continuous low dose cyclophosphamide/methotrexate and fragmin (FraCM) for metastatic breast cancer Dr. Kathy Pritchard, Dr. Rob Buckman, and Dr. Don Sutherland


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.